Abstract
Characterising associations between the methylome, proteome and phenome may provide insight into biological pathways governing brain health. Here, we report an integrated DNA methylation and phenotypic study of the circulating proteome in relation to brain health. Methylome-wide association studies of 4,058 plasma proteins are performed (N=774), identifying 2,928 CpG-protein associations after adjustment for multiple testing. These were independent of known genetic protein quantitative trait loci (pQTLs) and common lifestyle effects. Phenome-wide association studies of each protein are then performed in relation to 15 neurological traits (N=1,065), identifying 405 associations between the levels of 191 proteins and cognitive scores, brain imaging measures or APOE e4 status. We uncover 35 previously unreported DNA methylation signatures for 17 protein markers of brain health. The epigenetic and proteomic markers we identify are pertinent to understanding and stratifying brain health.
Competing Interest Statement
R.E.M has received a speaker fee from Illumina and is an advisor to the Epigenetic Clock Development Foundation. A.M.M has previously received speakers fees from Illumina and Janssen and research grant funding from The Sackler Trust. R.F.H. has received consultant fees from Illumina. All other authors declare no competing interest
Funding Statement
This research was funded in whole or in part by the Wellcome Trust [104036/Z/14/Z 108890/Z/15/Z 221890/Z/20/Z]. For the purpose of open access the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. D.A.G. and R.F.H. are supported by funding from the Wellcome Trust 4-year PhD in Translational Neuroscience training the next generation of basic neuroscientists to embrace clinical research [108890/Z/15/Z]. R.I.M is supported by funding from the Wellcome Trust PhD for clinicians Edinburgh Clinical Academic Track for Veterinary Surgeons. D.L.Mc.C. and R.E.M. are supported by Alzheimers Research UK major project grant ARUKPG2017B10. R.E.M is supported by Alzheimers Society major project grant AS-PG-19b-010. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates (CZD/16/6) and the Scottish Funding Council (HR03006). Genotyping and DNA methylation profiling of the GS samples was carried out by the Genetics Core Laboratory at the Clinical Research Facility University of Edinburgh Scotland and was funded by the Medical Research Council UK and the Wellcome Trust (Wellcome Trust Strategic Award STratifying Resilience and Depression Longitudinally ([STRADL Reference 104036/Z/14/Z]). Proteomic analyses in STRADL were supported by Dementias Platform UK (DPUK). DPUK funded this work through core grant support from the Medical Research Council [MR/L023784/2]. C.H. is supported by an MRC University Unit Programme Grant MC_UU_00007/10 (QTL in Health and Disease). L.S. is funded by DPUK through MRC (grant no. MR/L023784/2) and the UK Medical Research Council Award to the University of Oxford (grant no. MC_PC_17215). L.S. also received support from the NIHR Biomedical Research Centre at Oxford Health NHS Foundation Trust. S.R.C is supported by the Medical Research Council (MR/R024065/1) a National Institutes of Health research grant (R01AG054628) and a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant Number 221890/Z/20/Z). JDS is funded by MRC grants MR/S010351/1 MR/W002566/1 and MR/W002388/1. JMW is supported by the UK Dementia Research Institute which receives its funding from DRI Ltd funded by the UK Medical Research Council Alzheimers Society and Alzheimers Research UK. EB is supported by Stroke Association/BHF/Alzheimers Society Rates Risks and Routes to Reduce Vascular Dementia (R4VaD) Priority Programme Award in Vascular Dementia (16 VAD 07). The authors acknowledge the work of Rebecca Madden, Marco Squillace and Laura Klinkhamer who aided in the quality control of volumetric brain imaging data.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All components of GS received ethical approval from the NHS Tayside Committee on Medical Research Ethics (REC Reference Number: 05/S1401/89). GS has also been granted Research Tissue Bank status by the East of Scotland Research Ethics Service (REC Reference Number: 20/ES/0021), providing generic ethical approval for a wide range of uses within medical research.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data availability
Datasets generated in this study are made available in Supplementary Tables. Source data are provided with this paper.
Fully-adjusted MWAS summary statistics for protein levels are available through Zenodo [insert details once accepted files are uploaded] and hosted on the MRC-IEU EWAS catalog [insert details once accepted files are uploaded] 25.
A YouTube video summarising the findings of the study and detailing how to access files can be viewed at https://www.youtube.com/channel/UCxQrFFTIItF25YKfJTXuumQ.
The source datasets from the cohorts that were analysed during the current study are not publicly available due to them containing information that could compromise participant consent and confidentiality. Data can be obtained from the data owners. Instructions for accessing Generation Scotland data can be found here: https://www.ed.ac.uk/generation-scotland/for-researchers/access; the ‘GS Access Request Form’ can be downloaded from this site. Completed request forms must be sent to access{at}generationscotland.org to be approved by the Generation Scotland Access Committee.
